Clinical Trial Update: Effect of Aerobic Exercise on Side Effects of Disease Modifying Therapy With Subcutaneous Interferon-b1b in Patients With Multiple Sclerosis [NA]

View source ↗

Summary

Clinical trial update examining whether aerobic exercise reduces side effects of interferon beta-1b therapy in people with multiple sclerosis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Sclerosis

Drugs mentioned

• Interferon beta-1b (Interferon beta-1b)

Snippet

Sponsor: University of British Columbia | Conditions: Multiple Sclerosis | NA | Status: COMPLETED